Skip to content
value.today

Emerging Therapy Solutions, Inc.

🇺🇸 Edina, Minnesota, USAHealth CareFounded 2018
Total raised
$23 M
6 rounds on record
Latest round
$5 M
Mar 2024
First round on record
Dec 2018
Today
Private
No later event on record

Funding rounds

6 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Emerging Therapy Solutions, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2024$5 MNo. 6$2 to $10 million

Emerging Therapy Solutions, Inc.: Raise no. 6, Mar 2024

Investors in this round

5 investors had bought by the notice of Mar 26, 2024: 5 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ashley Hume · Executive Officer
  • Kevin Roche · Executive Officer, Director
  • Nathan Schmidt · Executive Officer
  • Gary Matthew Curtis · Director
  • J. Matthew Mackowski · Director
  • Larry Matthew Kocot · Director
  • Mike Matthew Burke · Director
  • Ravi Matthew Nalliah · Director
  • Rob Matthew Capone · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Nate Schmidt, Chief Financial and Administrative Officer. Source: SEC Form D, newest notice filed Mar 26, 2024. Read the notice at the SEC.

equitySEC
Dec 2022$3 MNo. 5$2 to $10 million

Emerging Therapy Solutions, Inc.: Raise no. 5, Dec 2022

Investors in this round

5 investors had bought by the notice of Dec 20, 2022: 5 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M (amount offered: indefinite)
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David McLean · Executive Officer, Director
  • Kevin Roche · Executive Officer, Director
  • Gary Matthew Curtis · Director
  • J. Matthew Mackowski · Director
  • Mike Matthew Burke · Director
  • Ravi Matthew Naliah · Director
  • Rob Matthew Capone · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by David McLean, Ceo. Source: SEC Form D, newest notice filed Dec 20, 2022. Read the notice at the SEC.

equitySEC
Jun 2021$6 MNo. 4$2 to $10 million

Emerging Therapy Solutions, Inc.: Raise no. 4, Jun 2021

Investors in this round

5 investors had bought by the notice of Jun 7, 2021: 5 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M (amount offered: indefinite)
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David McLean · Executive Officer, Director
  • Kevin Roche · Executive Officer, Director
  • J. Matthew Mackowski · Director
  • Jeanette Matthew Welsh · Director
  • Ravi Matthew Nalliah · Director
  • Steve Matthew Lefar · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by David McLean, Ceo. Source: SEC Form D, newest notice filed Jun 7, 2021. Read the notice at the SEC.

equitySEC
Feb 2020$3 MNo. 3$2 to $10 million

Emerging Therapy Solutions, Inc.: Raise no. 3, Feb 2020

Investors in this round

5 investors had bought by the notice of Feb 18, 2020: 5 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David McLean · Executive Officer, Director
  • Kevin Roche · Executive Officer, Director
  • J. Matthew Mackowski · Director
  • Jeanette Matthew Welsh · Director
  • Ravi Matthew Nalliah · Director
  • Steve Matthew Lefar · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by David McLean, Ceo. Source: SEC Form D, newest notice filed Feb 18, 2020. Read the notice at the SEC.

equitySEC
May 2019$1 MNo. 2Under $2 million

Emerging Therapy Solutions, Inc.: Raise no. 2, May 2019

Investors in this round

1 investor had bought by the notice of May 22, 2019: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David McLean · Executive Officer, Director
  • Kevin Roche · Executive Officer, Director
  • Jeanette Welsh · Director
  • Matt Mackowski · Director
  • Ravi Nalliah · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by David McLean, Ceo. Source: SEC Form D, newest notice filed May 22, 2019. Read the notice at the SEC.

equitySEC
Dec 2018$5 MNo. 1$2 to $10 million

Emerging Therapy Solutions, Inc.: Raise no. 1, Dec 2018

Investors in this round

4 investors had bought by the notice of Jan 4, 2019: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M (amount offered: indefinite)
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David McLean · Executive Officer, Director
  • Kevin Roche · Executive Officer, Director
  • Jeanette Welsh · Director
  • Matt Mackowski · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by David McLean, Ceo. Source: SEC Form D, newest notice filed Jan 4, 2019. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Emerging Therapy Solutions, Inc. chose not to state its revenue in its newest notice of a funding round (Mar 2024).

    SEC Form D · Mar 2024

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Mar 2024

That is all the official record says: Emerging Therapy Solutions, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Emerging Therapy Solutions, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 6 rounds above had up to 5 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Emerging Therapy Solutions, Inc.
NameRoleNamed in
Ashley HumeExecutive officerMar 2024
Kevin RocheExecutive officerMar 2024
Nathan SchmidtExecutive officerMar 2024
David McLeanExecutive officerDec 2022
Gary Matthew CurtisDirectorMar 2024
J. Matthew MackowskiDirectorMar 2024
Kevin RocheDirectorMar 2024
Larry Matthew KocotDirectorMar 2024
Mike Matthew BurkeDirectorMar 2024
Ravi Matthew NalliahDirectorMar 2024
Rob Matthew CaponeDirectorMar 2024
David McLeanDirectorDec 2022
Ravi Matthew NaliahDirectorDec 2022
Jeanette Matthew WelshDirectorJun 2021
Steve Matthew LefarDirectorJun 2021
Jeanette WelshDirectorMay 2019
Matt MackowskiDirectorMay 2019
Ravi NalliahDirectorMay 2019